Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Revolution Medicines' stock has seen significant gains, with some reports indicating it is up nearly 140% in 2026, while others suggest a 97% increase. However, the stock's value has also experienced fluctuations, with it plummeting by almost 17% on one day and surging by 11% on another. The company's valuation and potential for future growth are being debated, with some outlets discussing its potential as a game-changer and others weighing the bull and bear cases.
Full coverage
123456